Drug profile · INN
sodium benzoate
PROHIPPUR
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
sodium benzoate (PROHIPPUR) is an FDA-listed pharmaceutical active ingredient. Associated with MAIA Biotechnology. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN sodium benzoate
Brand PROHIPPUR
Route ORAL
Formulation SOLUTION
ATC code A16AX11
Originator MAIA Biotechnology
Frequently asked questions
What is sodium benzoate?
sodium benzoate (PROHIPPUR) is an FDA-listed pharmaceutical active ingredient. Associated with MAIA Biotechnology. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for sodium benzoate?
PROHIPPUR is a marketed brand name for sodium benzoate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of sodium benzoate?
sodium benzoate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.